DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Zugmaier G, Gökbuget N, Klinger M. et al.
Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment.
Blood 2015;
126 (24) 2578-2584
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.